CAN-2409

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant GliomaNCT00589875CADLPhase 2Completed2015-12Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.